Search

Search Constraints

You searched for: Author/Creator Ubink, Ruud

Search Results

1. A comparison of anti-HER2 IgA and IgG1 in vivo efficacy is facilitated by high N-glycan sialylation of the IgA. Issue 1 (2nd January 2016)

2. Discovery of SYD5115, a novel orally active small molecule TSH-R antagonist. (15th April 2023)

3. Improved in vivo anti-tumor effects of IgA-Her2 antibodies through half-life extension and serum exposure enhancement by FcRn targeting. Issue 1 (2nd January 2016)